Pharsight

IMMATICS BIOTECHNOLOGIES patents facing oppositions

Top patents of IMMATICS BIOTECHNOLOGIES facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3236985B2 25 Sep, 2019 Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers NA 1